MedTrace Logo

Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure

NCT04564378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2024-10-01

No results posted yet for this study

Summary

This study is being done to discover if there is a link between estrogen exposure and the severity of Fuchs Endothelial Corneal Disease. We are trying to understand if the decrease in estrogen levels in post-menopausal women may be a reason why FECD is seen more often in women than men.

Conditions

  • Fuchs Dystrophy

Interventions

OTHER

This is an observational study. There is no therapeutic intervention.

This is an observational study. There is no therapeutic intervention.

Sponsors & Collaborators

  • State University of New York at Buffalo

    lead OTHER

Principal Investigators

  • Sagita Patel · The Ross Eye Institute

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-17
Primary Completion
2023-04-27
Completion
2023-09-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04564378 on ClinicalTrials.gov